Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

If you work with strings in your Python scripts and you're writing obscure logic to process them, then you need to look into ...

Working It is the FT's workplace, future of work and leadership brand, led by Isabel Berwick. Sign up for Isabel's weekly Working It newsletter (here) which offers a sideways glance at the week's big ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.

Get the latest Replimune Group, Inc. (REPL) stock news and headlines to help you in your trading and investing decisions.